Unknown

Dataset Information

0

Nrf2 gene mutation and single nucleotide polymorphism rs6721961 of the Nrf2 promoter region in renal cell cancer.


ABSTRACT: BACKGROUND:Nuclear factor erythroid 2-related factor 2 (Nrf2) is involved in cell proliferation by promotion of metabolic activity. It is also the major regulator of antioxidants and has a pivotal role in tumor cell proliferation and resistance to chemotherapy. Accordingly, we investigated the role of Nrf2 in renal cell carcinoma (RCC). METHODS:In 50 patients who had metastatic RCC and received cytoreductive nephrectomy, we performed Nrf2 gene mutation analysis using targeted next-generation sequencing, as well as investigating a specific single nucleotide polymorphism (SNP; rs6721961) in the Nrf2 promoter region and Nrf2 protein expression. RESULTS:Targeted next-generation sequencing revealed that five tumors had SNPs of Nrf2 associated with amino acid sequence variation, while 11 tumors had SNPs of Kelch-like ECH-associated protein 1 gene, 35 had SNPs of von Hippel-Lindau gene, and none had SNPs of fumarate hydratase gene. The three genotypes of rs6721961 showed the following frequencies: 60% for C/C, 34% for C/A, and 6% for A/A. Nrf2 mutation and the C/A or A/A genotypes were significantly associated with increased Nrf2 protein expression (p =?0.0184 and p =?0.0005, respectively). When the primary tumor showed Nrf2 gene mutation, the C/A or A/A genotype, or elevated Nrf2 protein expression, the response of metastases to vascular endothelial growth factor-targeting therapy was significantly worse (p =?0.0142, p =?0.0018, and p 

SUBMITTER: Yamaguchi Y 

PROVIDER: S-EPMC6873559 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Nrf2 gene mutation and single nucleotide polymorphism rs6721961 of the Nrf2 promoter region in renal cell cancer.

Yamaguchi Yoshiyuki Y   Kamai Takao T   Higashi Satoru S   Murakami Satoshi S   Arai Kyoko K   Shirataki Hiromichi H   Yoshida Ken-Ichiro KI  

BMC cancer 20191121 1


<h4>Background</h4>Nuclear factor erythroid 2-related factor 2 (Nrf2) is involved in cell proliferation by promotion of metabolic activity. It is also the major regulator of antioxidants and has a pivotal role in tumor cell proliferation and resistance to chemotherapy. Accordingly, we investigated the role of Nrf2 in renal cell carcinoma (RCC).<h4>Methods</h4>In 50 patients who had metastatic RCC and received cytoreductive nephrectomy, we performed Nrf2 gene mutation analysis using targeted next  ...[more]

Similar Datasets

| S-EPMC2876206 | biostudies-literature
| S-EPMC4102818 | biostudies-literature
| S-EPMC2840562 | biostudies-literature
| S-EPMC5148830 | biostudies-literature
| S-EPMC3084244 | biostudies-literature
| S-EPMC7606242 | biostudies-literature
2010-06-25 | E-GEOD-16019 | biostudies-arrayexpress
| S-EPMC2883967 | biostudies-literature
| S-EPMC2749566 | biostudies-literature
| S-EPMC4009577 | biostudies-literature